Security Snapshot

Inventiva S.A. - Ordinary Shares, (euro)0.01 par value per share (IVA) Institutional Ownership

CUSIP: 46124U107

13F Institutional Holders and Ownership History from Q3 2020 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

53

Shares (Excl. Options)

46,711,433

Price

$4.65

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Type / Class
Equity / Ordinary Shares, (euro)0.01 par value per share
Symbol
IVA on Nasdaq
Shares outstanding
191,273,265
Price per share
$5.50
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
46,711,433
Total reported value
$217,189,873
% of total 13F portfolios
0%
Share change
+32,929,767
Value change
+$153,107,827
Number of holders
53
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • IVA - Inventiva S.A. - Ordinary Shares, (euro)0.01 par value per share is tracked under CUSIP 46124U107.
  • 53 institutions reported positions in Q4 2025.
  • 10 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 53 to 10 between Q4 2025 and Q1 2026.
  • Reported value moved from $217,189,873 to $15,100,746.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 53 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 46124U107?
CUSIP 46124U107 identifies IVA - Inventiva S.A. - Ordinary Shares, (euro)0.01 par value per share in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of Inventiva S.A. - Ordinary Shares, (euro)0.01 par value per share (IVA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Sofinnova Crossover I 8.6% +20% $108,981,346 +$64,487,273 19,086,050 +145% Sofinnova Partners SAS, a French corporation 31 Dec 2025
Invus Global Management, LLC 11% +35% $49,037,031 +$24,518,517 14,814,813 +100% Invus Public Equities, L.P. 30 Jun 2025
Andera Partners 7.7% -12% $80,593,658 +$10,381,814 14,114,476 +15% Andera Partners 31 Dec 2025
Samsara BioCapital, L.P. 7.4% +25% $56,191,805 +$22,319,746 13,540,194 +66% Srinivas Akkaraju 17 Nov 2025
Deep Track Capital, LP 6.1% $53,618,977 11,668,983 Deep Track Capital, LP 23 Jan 2026
BIOTECHNOLOGY VALUE FUND L P 5% -18% $39,714,931 +$4,251,111 9,569,863 +12% BVF PARTNERS L P/IL 17 Nov 2025
New Enterprise Associates 17, L.P. 4.9% -18% $57,827,646 +$6,303,642 9,372,390 +12% New Enterprise Associates 17, L.P. 30 Mar 2026
Yiheng Capital Management, L.P. 5.5% -36% $43,962,416 +$18,899,084 7,597,148 +75% Yiheng Capital Partners, L.P. 30 Sep 2025
PERCEPTIVE ADVISORS LLC 5% -14% $42,246,764 +$10,098,434 7,300,666 +31% Perceptive Advisors LLC 30 Sep 2025
Broqua Pierre 4.3% $15,365,625 4,097,500 Pierre Broqua 31 Dec 2024

As of 31 Dec 2025, 53 institutional investors reported holding 46,711,433 shares of Inventiva S.A. - Ordinary Shares, (euro)0.01 par value per share (IVA). This represents 24% of the company’s total 191,273,265 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Inventiva S.A. - Ordinary Shares, (euro)0.01 par value per share (IVA) together control 23% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
SAMSARA BIOCAPITAL, LLC 2.7% 5,194,805 2.5% $24,155,843
Paradigm Biocapital Advisors LP 2.1% 4,000,000 0.5% $18,600,000
ADAR1 Capital Management, LLC 1.4% 2,709,846 0.94% $12,600,784
Trails Edge Capital Partners, LP 1.4% 2,657,997 0% 3.1% $12,359,686
MILLENNIUM MANAGEMENT LLC 1.4% 2,652,570 +2268% 0.01% $12,334,450
UBS Group AG 1.4% 2,643,702 +28882% 0% $12,293,214
SymBiosis Capital Partners, LLC 1.4% 2,600,000 0% 13% $12,090,000
FRANKLIN RESOURCES INC 1.3% 2,500,141 0% $11,625,656
Caligan Partners LP 1% 2,000,000 0.85% $9,300,000
Polar Capital Holdings Plc 1% 1,998,880 0.04% $9,294,792
ANDERA PARTNERS 0.95% 1,818,181 0% 4.8% $8,454,542
Yu Fan 0.78% 1,500,000 7.6% $6,975,000
Ally Bridge Group (NY) LLC 0.78% 1,500,000 11% $6,975,000
NEA Management Company, LLC 0.76% 1,462,586 0% 0.35% $6,801,025
RTW INVESTMENTS, LP 0.68% 1,298,701 0.06% $6,038,960
NEXTBio Capital Management LP 0.68% 1,298,701 0% 3.5% $6,038,960
Propel Bio Management, LLC 0.52% 1,000,000 4% $4,650,000
BVF INC/IL 0.36% 686,040 0% 0.11% $3,190,086
BOOTHBAY FUND MANAGEMENT, LLC 0.34% 658,971 0.08% $3,064,215
AMERIPRISE FINANCIAL INC 0.32% 615,473 0% $2,861,950
J. Goldman & Co LP 0.27% 516,445 0.09% $2,401,469
MORGAN STANLEY 0.27% 507,701 +1605% 0% $2,360,810
Ikarian Capital, LLC 0.26% 502,601 0.3% $2,328,852
Alyeska Investment Group, L.P. 0.26% 500,000 0.01% $2,325,000
Deep Track Capital, LP 0.26% 490,000 0.05% $2,278,500

Institutional Holders of Inventiva S.A. - Ordinary Shares, (euro)0.01 par value per share (IVA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 2,721,282 $15,100,746 -$2,029,126 $5.55 10
2025 Q4 46,711,433 $217,189,873 +$153,107,827 $4.65 53
2025 Q3 5,106,787 $29,415,940 +$1,094,859 $5.79 15
2025 Q2 4,928,159 $15,667,628 +$214,859 $3.19 12
2025 Q1 4,860,363 $12,214,319 -$1,721,340 $2.94 8
2024 Q4 5,447,098 $11,663,912 +$1,275,982 $2.14 7
2024 Q3 4,851,351 $9,059,439 -$1,414 $1.86 7
2024 Q2 4,845,553 $14,461,203 -$19,438 $2.99 7
2024 Q1 4,849,836 $17,555,978 -$52,773 $3.62 8
2023 Q4 4,860,874 $21,917,529 +$26,077 $4.52 8
2023 Q3 4,855,354 $20,589,732 +$102,187 $4.20 7
2023 Q2 4,830,074 $19,513,567 -$1,019,078 $4.04 8
2023 Q1 5,129,875 $18,275,932 +$1,089,878 $3.64 8
2022 Q4 4,812,252 $21,919,774 -$19,722,477 $4.44 6
2022 Q3 8,933,248 $33,067,000 -$1,003,809 $3.86 7
2022 Q2 9,109,429 $51,761,000 +$29,343,302 $5.77 10
2022 Q1 3,934,328 $45,020,000 +$2,060,118 $11.40 9
2021 Q4 3,755,787 $51,299,000 +$608,002 $13.66 10
2021 Q3 3,708,525 $52,500,000 +$30,368,738 $14.16 11
2021 Q2 1,564,469 $21,328,000 -$848,745 $13.58 14
2021 Q1 1,623,116 $23,833,940 -$15,643,566 $14.69 13
2020 Q4 2,733,996 $39,206,000 -$22,116,536 $14.50 15
2020 Q3 4,021,314 $47,498,000 +$47,498,000 $11.81 17
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .